Abstract:Under their own vapor pressure, all known liquids eventually freeze into a crystalline state if they are cooled to sufficiently low temperatures. The exception is helium-4, which crystallizes below 2 degrees kelvin only at the much higher pressure of 25.3 bar. (The pressure needed to induce crystallization is approximately independent of temperature down to 0 kelvin.) According to conventional wisdom, the reason liquid helium doesn’t crystallize at low temperature is that helium atoms are so light that their quantum-mechanical zero-point motion overwhelms the weak interaction between them. In a theoretical paper in Physical Review Letters, Massimo Boninsegni of the University of Alberta in Canada and colleagues [1] show this zero-point motion argument isn’t enough to explain why helium-4 doesn’t crystallize at low pressure. Instead, the fact that helium-4 atoms are bosons and thus, in contrast to classical particles, indistinguishable, also impedes the formation of crystalline helium. Boninsegni et al.’s work illuminates the general role of Bose statistics in crystallization and emphasizes its importance in determining the phase diagram of helium-4 and other systems consisting of interacting bosonic particles. In contrast to classical particles, which can be labeled and thus distinguished, quantum mechanical particles are indistinguishable. The quantum mechanical wave function that describes two identical bosons must be symmetric with respect to the variables describing each particle; that is, if the variables for particle 1 and particle 2 are swapped, the wave function describing the two particles stays the same. A convenient way to visualize this symmetry is to use Feynman’s path integrals, which makes an analogy between the quantum mechanics of a particle and the fluctuations of a peculiar type of classical polymer [2]. In this picture, several quantum particles are like a bunch of floppy spaghetti. The polymer analogy is helpful for calculating a system of quantum particles’ partition function—a sum over the allowed states, weighted by their energy, which is used in the calculation of thermodynamic quantities and phase diagrams. Formally, the partition function of a ddimensional, quantum mechanical, many-particle system of bosons is identical to the partition function of a system of soft polymers confined to a (d+ 1)-dimensional box of height 1/T , where T is the temperature of the original quantum system (Fig. 1). This classical partition function is computed by integrating over all possible configurations or arrangements of polymers, each of which is weighted according to its cost in energy (the more a polymer has to bend, the less the path will be weighted). A peculiar feature of this configuration space is that it must have periodic boundary conditions in the height direction in order for the polymer problem to map to the quantum one, which means that polymer positions within the bottom and top plane of the box have to be identical, as sketched in Fig. 1. This is why the distinguishability of the particles is important: If the original quantum mechanical particles are distinguishable (Boninsegni et al. call such particles boltzmannons [1]), then, in the polymer picture, each polymer has to enter and exit at the same point in the bottom and top side, respectively (see Fig. 1(a)). But, if the original quantum mechanical particles are bosons, the entry and exit points of a polymer can be different, yielding polymer configurations that wrap around the box several times, called exchange cycles. All these configurations with arbitrary exchange cycles have to be considered in the path integral for bosons, which means they have a larger configuration space than boltzmannons do.

[Acute coronary syndrome without ST-segment elevation. Current guidelines].

Hemophagocytic Lymphohistiocytosis Secondary to Acute Human Immunodeficiency Virus and COVID-19

Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report

Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and Candida auris Fungemia in Post-acute COVID-19 Syndrome: A Clinical Challenge

A CASE REPORT OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A POST-COVID-19 : AN EMERGING COMPLICATION

Hemophagocytic lymphohistiocytosis secondary to Candida albicans and reactivated EBV infections: A case report and review of the literature

Ruxolitinib As an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report.

Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination

The Twisted Paths of Bosons

Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in HIV Seronegative Patients: A Case Report and Review of the Literature.

Bio‐assay of Responses of Growing Bones to Cortisol

Metagenomic Next-Generation Sequencing in the Diagnosis of HHV-1 Reactivation in a Critically Ill COVID-19 Patient: A Case Report

Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature

Hemophagocytic lymphohistiocytosis after induction remission of acute promyelocytic leukemia:one case and literature review

XML tree structure compression using RePair

School completion: What we learn from different measures of family background

SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report

Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report

Successful Recovery of a Child with COVID-19-Induced Secondary Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis mimics many common conditions: case series and review of literature

Severe Acute Liver Injury due to Secondary Hemophagocytic Lymphohistiocytosis: A Case Report